The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation-Reference-Cited by-同舟云学术

The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation

Published:2018-03 Issue:3 Volume:68 Page:456-464
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Schlegel Andrea,Kalisvaart Marit,Scalera Irene,Laing Richard W.,Mergental Hynek,Mirza Darius F.,Perera Thamara,Isaac John,Dutkowski Philipp,Muiesan Paolo

Publisher

Elsevier BV

Subject

Hepatology

Reference47 articles.

1. Liver transplantation using donation after cardiac death donors;Monbaliu;J Hepatol,2012

2. Liver transplantation with grafts from controlled donors after cardiac death: a 20-year follow-up at a single center;Yamamoto;Am J Transplant,2010

3. Biliary complications after orthotopic liver transplantation from donors after cardiac death: broad spectrum of disease;Abbass;Transplant Proc,2010

4. Donation after cardiac death as a strategy to increase deceased donor liver availability;Merion;Ann Surg,2006

5. Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study;Callaghan;BMJ Open,2013

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Liver Transplantation From Hepatitis C Virus–positive DCD Donors and Its Utilization Among Centers in the United States;Transplantation;2024-08-22

2. Standardization is needed in reporting risk and outcomes of machine perfusion in liver transplantation;Hepatobiliary Surgery and Nutrition;2024-08

3. Normothermic regional perfusion in controlled DCD liver procurement: Outcomes of the Swedish national implementation protocol;Liver Transplantation;2024-07-23

4. Liver function maximum capacity test during normothermic regional perfusion predicts graft function after transplantation;EPMA Journal;2024-07-16

5. Commentary: DCD liver transplant in patients with a MELD over 35;Frontiers in Immunology;2024-07-11